192 related articles for article (PubMed ID: 35857497)
1. Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis.
Upchurch CM; Yeudall S; Pavelec CM; Merk D; Greulich J; Manjegowda M; Raghavan SS; Bochkis IM; Scott MM; Perez-Reyes E; Leitinger N
Sci Adv; 2022 Jul; 8(28):eabn0050. PubMed ID: 35857497
[TBL] [Abstract][Full Text] [Related]
2. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
Que X; Hung MY; Yeang C; Gonen A; Prohaska TA; Sun X; Diehl C; Määttä A; Gaddis DE; Bowden K; Pattison J; MacDonald JG; Ylä-Herttuala S; Mellon PL; Hedrick CC; Ley K; Miller YI; Glass CK; Peterson KL; Binder CJ; Tsimikas S; Witztum JL
Nature; 2018 Jun; 558(7709):301-306. PubMed ID: 29875409
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis.
Sun X; Seidman JS; Zhao P; Troutman TD; Spann NJ; Que X; Zhou F; Liao Z; Pasillas M; Yang X; Magida JA; Kisseleva T; Brenner DA; Downes M; Evans RM; Saltiel AR; Tsimikas S; Glass CK; Witztum JL
Cell Metab; 2020 Jan; 31(1):189-206.e8. PubMed ID: 31761566
[TBL] [Abstract][Full Text] [Related]
4. Analysis of fragmented oxidized phosphatidylcholines in human plasma using mass spectrometry: Comparison with immune assays.
Philippova M; Oskolkova OV; Bicker W; Schoenenberger AW; Resink TJ; Erne P; Bochkov VN
Free Radic Biol Med; 2019 Nov; 144():167-175. PubMed ID: 31141712
[TBL] [Abstract][Full Text] [Related]
5. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
[TBL] [Abstract][Full Text] [Related]
6. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.
Weber M; Mera P; Casas J; Salvador J; Rodríguez A; Alonso S; Sebastián D; Soler-Vázquez MC; Montironi C; Recalde S; Fucho R; Calderón-Domínguez M; Mir JF; Bartrons R; Escola-Gil JC; Sánchez-Infantes D; Zorzano A; Llorente-Cortes V; Casals N; Valentí V; Frühbeck G; Herrero L; Serra D
FASEB J; 2020 Sep; 34(9):11816-11837. PubMed ID: 32666604
[TBL] [Abstract][Full Text] [Related]
7. Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation.
Wu X; Zheng H; Yang R; Luan X; Zhang L; Jin Q; Jin Y; Xue J
Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E436-E445. PubMed ID: 31211621
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury.
Newberry EP; Xie Y; Lodeiro C; Solis R; Moritz W; Kennedy S; Barron L; Onufer E; Alpini G; Zhou T; Blaner WS; Chen A; Davidson NO
FASEB J; 2019 Mar; 33(3):4610-4625. PubMed ID: 30576225
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice.
Palmieri M; Almeida M; Nookaew I; Gomez-Acevedo H; Joseph TE; Que X; Tsimikas S; Sun X; Manolagas SC; Witztum JL; Ambrogini E
Aging Cell; 2021 Aug; 20(8):e13442. PubMed ID: 34278710
[TBL] [Abstract][Full Text] [Related]
10. Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.
Yeang C; Hasanally D; Que X; Hung MY; Stamenkovic A; Chan D; Chaudhary R; Margulets V; Edel AL; Hoshijima M; Gu Y; Bradford W; Dalton N; Miu P; Cheung DY; Jassal DS; Pierce GN; Peterson KL; Kirshenbaum LA; Witztum JL; Tsimikas S; Ravandi A
Cardiovasc Res; 2019 Jan; 115(1):179-189. PubMed ID: 29850765
[TBL] [Abstract][Full Text] [Related]
11. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
12. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
14. Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis.
Jiang X; Fulte S; Deng F; Chen S; Xie Y; Chao X; He XC; Zhang Y; Li T; Li F; McCoin C; Morris EM; Thyfault J; Liu W; Li L; Davidson NO; Ding WX; Ni HM
J Hepatol; 2022 Sep; 77(3):619-631. PubMed ID: 35452693
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
16. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.
Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609
[TBL] [Abstract][Full Text] [Related]
17. iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes.
Zhu X; Gan-Schreier H; Otto AC; Cheng Y; Staffer S; Tuma-Kellner S; Ganzha A; Liebisch G; Chamulitrat W
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):677-687. PubMed ID: 30735854
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD.
Marsal-Beltran A; Rodríguez-Castellano A; Astiarraga B; Calvo E; Rada P; Madeira A; Rodríguez-Peña MM; Llauradó G; Núñez-Roa C; Gómez-Santos B; Maymó-Masip E; Bosch R; Frutos MD; Moreno-Navarrete JM; Ramos-Molina B; Aspichueta P; Joven J; Fernández-Real JM; Quer JC; Valverde ÁM; Pardo A; Vendrell J; Ceperuelo-Mallafré V; Fernández-Veledo S
Metabolism; 2023 Aug; 145():155630. PubMed ID: 37315889
[TBL] [Abstract][Full Text] [Related]
19. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.
Palmieri M; Kim HN; Gomez-Acevedo H; Que X; Tsimikas S; Jilka RL; Manolagas SC; Witztum JL; Ambrogini E
J Bone Miner Res; 2021 Jan; 36(1):170-185. PubMed ID: 32990984
[TBL] [Abstract][Full Text] [Related]
20. Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
Mendel I; Yacov N; Shoham A; Ishai E; Breitbart E
Dig Dis Sci; 2016 Sep; 61(9):2545-53. PubMed ID: 27074921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
